139
Participants
Start Date
June 28, 2017
Primary Completion Date
May 4, 2023
Study Completion Date
May 4, 2023
Pamiparib
Administered by mouth as a capsule twice daily
Temozolomide
TMZ at various doses administered by mouth as a capsule once daily.
Saint Vincents Hospital Sydney, Darlinghurst
Chris Obrien Lifehouse, Camperdown
Peter Maccallum Cancer Centre, Melbourne
Icon Cancer Centre South Brisbane, South Brisbane
Mount Sinai Prime, New York
Montefiore Medical Park At Eastchester Einstein Campus, The Bronx
Hospital Universitario Ramon Y Cajal, Madrid
Start Madrid Fundacion Jimenez Diaz, Madrid
Centro Integral Oncologico Clara Campal, Madrid
Sarah Cannon Cancer Center, Nashville
Hospital Universitario Virgen de La Macarena, Seville
Hospital Clinico Universitario de Valencia, Valencia
Start Midwest, Grand Rapids
Washington University in St Louis, St Louis
Texas Oncology (Loop) Usor, Dallas
The University of Texas Md Anderson Cancer Center, Houston
Hospital Universitario Vall Dhebron, Barcelona
Ico H Duran I Reynals, Barcelona
Beatson West of Scotland Cancer Centre, Glasgow
Northern Centre For Cancer Care, High Heaton
University College Hospital, London
Sarah Cannon Research Institute Uk, London
Lead Sponsor
Collaborators (1)
Myriad Genetics, Inc.
INDUSTRY
BeiGene
INDUSTRY